» Go to news main
Bringing Dal‑developed cancer treatment technology to the world
A new $2.1-million investment from the federal government will help Dal researchers build on advances in precision cancer-treatment technology and bring them more quickly to patients in need around the world.
Faculty of Medicine researcher James Robar, chief of Medical Physics at the Nova Scotia Health Authority (NSHA) and director of Dal’s Medical Physics program, and his team will use the funds to expand their work on developing and improving technologies that allow doctors to deploy radiation treatment in more precise, less-invasive ways that improve patient outcomes.
Dr. Robar provided attendees with a brief overview of each technology. They range from a capacitive patient-monitoring system that provides sensitive readouts many times a second about where a patient is during treatment to an algorithm that can enable more precisely target radiation treatments that result in less damage to surrounding healthy organs and tissue.
“We know that we have to move beyond and further than publishing papers and theses because we want these ideas to reach and benefit patients,” said Dr. Robar, crediting Brainlab for its help in giving his team a channel for technologies that “began as ideas on a whiteboard.”
Read more on Dal News.
Recent News
- Leading the way: Dal’s 2024 university wide teaching award winners exemplify excellence in higher ed
- Faculty of Medicine presents awards at annual faculty meeting
- Dalhousie Stands Out Amid National Downward Matching Trend
- Dr. Sara Folkins receives C. B. Stewart Medal recognizing academic excellence
- Channelling the power of Natural Killer cells to beat cancer
- Rare disease specialist returns to Dalhousie
- Ophthalmologist, author receives Gold‑Headed Cane Award
- Celebrating the Class of 2024